HealthcareServices

Global Synthetic Biology Market Forecast 2026–2035: Long-Term Growth Insights

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the synthetic biology market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Synthetic Biology Market between 2026 and 2030?

The synthetic biology market has witnessed substantial growth in recent years. It is anticipated to expand from $26.63 billion in 2025 to $32 billion in 2026, indicating a compound annual growth rate (CAGR) of 20.2%. The progress observed historically can be ascribed to advancements in genetic engineering techniques, increased funding for academic and industrial research, the expanding availability of sequencing technologies, the early introduction of synthetic organisms to the market, and strengthened partnerships between academia and industry.

The synthetic biology market is projected to experience substantial expansion in the next few years, with its size expected to reach $62.48 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.2%. This growth over the forecast period is propelled by increasing investments in bio-manufacturing, a rising demand for sustainable chemicals and fuels, the expansion of synthetic biology applications within healthcare, the growing integration of AI-driven biological design, and increasing regulatory clarity for engineered organisms. Prominent trends anticipated in this period include the wider adoption of CRISPR-based gene editing, the rising use of bioinformatics-driven design tools, the expansion of synthetic gene construction platforms, a growing focus on sustainable bio-based production, and enhanced automation in biological engineering workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2508&type=smp

Which Drivers Are Expected To Impact The Synthetic Biology Market During The Forecast Period?

Increased investment in research and development is anticipated to propel the growth of the synthetic biology market. Research and development (R&D) is defined as the methodical process of creating new knowledge, technologies, or products through systematic investigation, experimentation, and innovation, aiming to enhance existing offerings or develop entirely new ones. The upsurge in R&D investments stems from intensifying competition, the growing demand for innovation, continuous advancements in technology, and the necessity for businesses to adapt to shifting consumer preferences and market dynamics. Investing in research and development for synthetic biology is crucial to unlocking the field’s potential for generating sustainable solutions in sectors such as healthcare, agriculture, and environmental management, achieved by engineering biological systems and organisms for precise purposes. For instance, according to the Office for National Statistics, a UK-based government agency, the UK government’s net spending on research and development (R&D) climbed to £17.4 billion ($22.1 billion) in 2023, an increase from £16.1 billion ($20.45 billion) in 2022, indicating an 8.2% rise. Therefore, the expanding investment in research and development is actively driving the synthetic biology market’s expansion.

How Is The Synthetic Biology Market Divided Into Segments?

The synthetic biology market covered in this report is segmented –

1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering

2) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism

3) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application

Subsegments:

1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies, Next-Generation Sequencing (NGS), Sanger Sequencing

2) By Bioinformatics: Software Tools For Genomic Data Analysis, Databases For Gene/Protein Information, Algorithms For Gene Editing And Design

3) By Microfluidics: Lab-On-A-Chip Technologies, Microfluidic Devices For Biological Assays, Applications In Drug Discovery And Diagnostics

4) By Genetic Engineering: CRISPR/Cas9 Technology, Recombinant DNA Technology, Synthetic Gene Construction And Assembly

What Industry Trends Are Transforming The Synthetic Biology Market?

Leading companies within the synthetic biology market are increasingly focusing on developing innovative products, such as custom solutions programs that utilize design-build-test cycles to accelerate unique synthetic biology projects. A custom solutions program represents a personalized service, enabling clients to directly collaborate with experts to design, construct, and test synthetic DNA constructs, rather than relying on standard catalog offerings. For instance, in June 2025, Integrated DNA Technologies (IDT), a U.S.-based biotechnology company, introduced its Synthetic Biology Custom Solutions Program. This premium manufacturing service provides customers access to IDT’s in-house scientists and engineers to work on tailored projects, encompassing everything from complex genes to non-standard DNA fragments. Key aspects of this program include a dedicated team supporting design-build-test workflows, bespoke manufacturing at IDT’s 25,000-sq-ft synthetic biology facility, broad acceptance of diverse project types (e.g., high-yield non-standard gene fragments, genes >5 kb, multi-site cloning), and expedited turnaround times achieved by removing rigid high-throughput limitations. This initiative empowers innovators in synthetic biology to iterate more rapidly and overcome common bottlenecks in their R&D.

Which Major Industry Participants Are Leading The Synthetic Biology Market Growth?

Major companies operating in the synthetic biology market are Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Synthetic Biology Market?

North America was the largest region in the synthetic biology market in 2025. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Synthetic Biology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2508&type=smp

Browse Through More Reports Similar to the Global Synthetic Biology Market 2026, By The Business Research Company

Computational Biology Market Report 2026

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Synthetic Food Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-food-global-market-report

Synthetic Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795